| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM4 VIL1 TPR DLG5 NRAP MAP1B HAP1 CKAP5 MYRIP NEB DCTN1 CCDC88C CCDC66 BRCA2 EGFR P4HB AGBL1 PLS1 SPATA4 MTSS2 | 5.50e-05 | 1099 | 136 | 20 | GO:0008092 |
| GeneOntologyCellularComponent | sperm end piece | 1.29e-04 | 3 | 138 | 2 | GO:0097229 | |
| GeneOntologyCellularComponent | cilium | DLG5 DNAH10 MAP1B FSIP1 MYRIP DZIP1 DCTN1 CC2D2B FSIP2 AKAP4 CCDC66 AKAP9 BBS7 CPLANE1 TOPORS SPATA4 | 2.92e-04 | 898 | 138 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | ciliary basal body | 3.19e-04 | 195 | 138 | 7 | GO:0036064 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 TPR CCT3 MAP1B RPAP3 ECD ETFA RSF1 CKAP5 PDCD2L ARFIP1 DCTN1 NSUN2 TRIP11 R3HCC1L SMG7 AGFG1 BOD1L1 CGNL1 SIPA1L2 SMCR8 ZNF281 RPL3 ZC3HAV1 | 5.83e-13 | 934 | 141 | 24 | 33916271 |
| Pubmed | CASP8AP2 DLG5 MIA3 RPAP3 ZC3H13 ECD ETFA BMS1 LMNB2 DZIP1 ARFIP1 DCTN1 DICER1 DMXL1 PAXBP1 R3HCC1L AKAP9 EGFR P4HB BBS7 HGS ZRANB2 SIPA1L2 SMCR8 SUCO RPL3 ZC3HAV1 | 5.37e-11 | 1487 | 141 | 27 | 33957083 | |
| Pubmed | TPP2 TPR CCT3 MAP1B ZC3H13 RSF1 BMS1 CKAP5 LMNB2 NSUN2 TRIP12 DICER1 P4HB DDX20 RPL3 ZMYM3 ZC3HAV1 | 1.49e-09 | 653 | 141 | 17 | 22586326 | |
| Pubmed | 1.35e-08 | 267 | 141 | 11 | 33417871 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYC TPR DIS3L2 ERCC6 CCT3 MAP1B RPAP3 RSF1 BMS1 CKAP5 LMNB2 DCTN1 NSUN2 TRIP12 P4HB SERPINB3 SERPINB4 DDX20 ZNF281 RPL3 ZMYM3 ZC3HAV1 | 2.93e-08 | 1353 | 141 | 22 | 29467282 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VIL1 ATRN CCT3 TOPAZ1 ZC3H13 BMS1 CKAP5 LMNB2 ZZEF1 TRIP12 R3HCC1L EBLN1 AGL BOD1L1 PLS1 MEGF10 | 5.71e-08 | 736 | 141 | 16 | 29676528 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 MIA3 RPAP3 ECD ETFA CKAP5 DCTN1 CCDC88C CCDC66 SMG7 BRCA2 HGS RASEF CGNL1 SIPA1L2 CPLANE1 ZC3HAV1 | 7.45e-08 | 853 | 141 | 17 | 28718761 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 MAP1B CKAP5 DZIP1 TRIP12 TRIP11 FSIP2 CCDC88C NHSL1 AKAP9 AGFG1 FNIP1 BOD1L1 CGNL1 SIPA1L2 MTSS2 ZC3HAV1 | 8.50e-08 | 861 | 141 | 17 | 36931259 |
| Pubmed | TPM4 VIL1 CCT3 MAP1B ECD GPS1 RSF1 SKIDA1 MYRIP AHCYL2 LMNB2 NEB DCTN1 TRIP12 NEDD8 P4HB SYCP1 BOD1L1 SIPA1L2 RPL3 PLS1 PHTF1 | 8.91e-08 | 1442 | 141 | 22 | 35575683 | |
| Pubmed | TPR CASP8AP2 RPAP3 CKAP5 ZDBF2 DCTN1 NEDD8 ZFHX4 BRCA2 ZNF532 ZFHX3 ZMYM3 | 1.53e-07 | 418 | 141 | 12 | 34709266 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 TPR DLG5 ERCC6 COL17A1 CCT3 RPAP3 ZC3H13 ECD BMS1 CKAP5 LMNB2 NSUN2 TRIP12 EGFR P4HB SERPINB3 TOPORS RPL3 ZC3HAV1 | 1.89e-07 | 1257 | 141 | 20 | 36526897 |
| Pubmed | TPR DLG5 CCT3 MAP1B RPAP3 ICE2 CKAP5 ARFIP1 SLC38A1 EGFR HGS BOD1L1 SMCR8 RPL3 ZC3HAV1 | 2.11e-07 | 708 | 141 | 15 | 39231216 | |
| Pubmed | TPR CCT3 MAP1B ZC3H13 BMS1 CKAP5 NSUN2 CCDC88C PAXBP1 P4HB DDX20 RPL3 ZC3HAV1 | 4.29e-07 | 551 | 141 | 13 | 34728620 | |
| Pubmed | A-kinase anchoring protein 4 binding proteins in the fibrous sheath of the sperm flagellum. | 6.48e-07 | 5 | 141 | 3 | 12606363 | |
| Pubmed | Engrailed transcription factors direct excitatory cerebellar neuron diversity and survival. | 7.58e-07 | 18 | 141 | 4 | 38912572 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CASP8AP2 DLG5 ZDBF2 TRIP11 SMG7 BRCA2 AGFG1 DDX20 CGNL1 SIPA1L2 TOPORS LRIF1 ZMYM3 | 8.88e-07 | 588 | 141 | 13 | 38580884 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.11e-06 | 256 | 141 | 9 | 33397691 | |
| Pubmed | 1.38e-06 | 263 | 141 | 9 | 34702444 | ||
| Pubmed | 2.26e-06 | 7 | 141 | 3 | 16735510 | ||
| Pubmed | 2.38e-06 | 209 | 141 | 8 | 36779422 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 2.64e-06 | 212 | 141 | 8 | 33853758 | |
| Pubmed | 3.61e-06 | 26 | 141 | 4 | 30121012 | ||
| Pubmed | CCT3 BMS1 ARFIP1 TRIP12 TRIP11 DMXL1 SLC38A1 EGFR ZRANB2 ZFHX3 CGNL1 SMCR8 RPL3 ZC3HAV1 | 3.63e-06 | 777 | 141 | 14 | 35844135 | |
| Pubmed | TPR ERCC6 CCT3 AKAP9 P4HB SERPINB3 SERPINB4 TRPM8 AGBL1 RPL3 | 3.92e-06 | 382 | 141 | 10 | 37249651 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM4 TPP2 TPR CCT3 RPAP3 ECD CKAP5 PDCD2L AHCYL2 DCTN1 NSUN2 PAXBP1 EGFR P4HB AGL ZRANB2 DDX20 RPL3 ZC3HAV1 | 4.76e-06 | 1415 | 141 | 19 | 28515276 |
| Pubmed | ETFA TRIP11 ADGRL4 CC2D2B SLC38A1 EVI5 MELTF PPP2R5A PTPRZ1 SYCP1 SUN3 LRRD1 ZC3HAV1 | 4.80e-06 | 686 | 141 | 13 | 29987050 | |
| Pubmed | MYC TPM4 TPR CASP8AP2 CCT3 NEB DCTN1 HGS AGFG1 CGNL1 CPLANE1 | 5.10e-06 | 486 | 141 | 11 | 20936779 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR CCT3 DNAH10 ETFA BMS1 CKAP5 LMNB2 DCTN1 NSUN2 DICER1 SLC38A1 PAXBP1 P4HB SERPINB3 ZRANB2 BOD1L1 DDX20 RPL3 ZC3HAV1 | 5.26e-06 | 1425 | 141 | 19 | 30948266 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | MYC CCT3 SKIDA1 LMNB2 TRIP12 NEDD8 ZRANB2 BOD1L1 ZNF281 LRIF1 ZMYM3 | 6.07e-06 | 495 | 141 | 11 | 27705803 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | CCT3 MAP1B GPS1 CKAP5 LMNB2 DCTN1 NEDD8 P4HB AGL ZRANB2 RPL3 | 6.07e-06 | 495 | 141 | 11 | 28581483 |
| Pubmed | DZIP1 ARFIP1 TRIP11 SLC38A1 NHSL1 EGFR HGS SIPA1L2 MTSS2 ZC3HAV1 | 9.17e-06 | 421 | 141 | 10 | 36976175 | |
| Pubmed | TOPORS-mediated RAD51 SUMOylation facilitates homologous recombination repair. | 1.05e-05 | 11 | 141 | 3 | 35061896 | |
| Pubmed | 1.20e-05 | 187 | 141 | 7 | 26460568 | ||
| Pubmed | MYC ERCC6 RSF1 PDCD2L ZZEF1 DICER1 NEDD8 PPP2R5A SMG7 ZFHX4 ZFHX3 SIPA1L2 TOPORS ZNF281 AGBL1 ZMYM3 | 1.28e-05 | 1116 | 141 | 16 | 31753913 | |
| Pubmed | Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure. | 1.63e-05 | 2 | 141 | 2 | 23354406 | |
| Pubmed | A germline point mutation in the MYC-FBW7 phosphodegron initiates hematopoietic malignancies. | 1.63e-05 | 2 | 141 | 2 | 38565249 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 14988024 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 18559552 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23521519 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8622882 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12606946 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 34255150 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22908258 | ||
| Pubmed | SCCA2-like serpins mediate genetic predisposition to skin tumors. | 1.63e-05 | 2 | 141 | 2 | 12702576 | |
| Pubmed | The mouse ZFH-4 protein contains four homeodomains and twenty-two zinc fingers. | 1.63e-05 | 2 | 141 | 2 | 10873665 | |
| Pubmed | Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins. | 1.63e-05 | 2 | 141 | 2 | 35022507 | |
| Pubmed | Squamous cell carcinoma antigen production in nasal inverted papilloma. | 1.63e-05 | 2 | 141 | 2 | 23168150 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 30068551 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10653592 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29112685 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10956412 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 35874657 | ||
| Pubmed | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. | 1.63e-05 | 2 | 141 | 2 | 27668655 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11857795 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23250739 | ||
| Pubmed | Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice. | 1.63e-05 | 2 | 141 | 2 | 21403642 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 11267667 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 29491058 | ||
| Pubmed | The Rak/Frk tyrosine kinase associates with and internalizes the epidermal growth factor receptor. | 1.63e-05 | 2 | 141 | 2 | 23318459 | |
| Pubmed | The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. | 1.63e-05 | 2 | 141 | 2 | 11863458 | |
| Pubmed | IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease. | 1.63e-05 | 2 | 141 | 2 | 22808225 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 31265868 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 30832751 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20428762 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 15203214 | ||
| Pubmed | Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility. | 1.63e-05 | 2 | 141 | 2 | 31047779 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 26204818 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 30770740 | ||
| Pubmed | Characterization of novel squamous cell carcinoma antigen-related molecules in mice. | 1.63e-05 | 2 | 141 | 2 | 15504361 | |
| Pubmed | The UIM domain of Hrs couples receptor sorting to vesicle formation. | 1.63e-05 | 2 | 141 | 2 | 12953068 | |
| Pubmed | EGFR-mediated epidermal stem cell motility drives skin regeneration through COL17A1 proteolysis. | 1.63e-05 | 2 | 141 | 2 | 34550317 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 25111616 | ||
| Pubmed | A gene regulatory network anchored by LIM homeobox 1 for embryonic head development. | 1.63e-05 | 2 | 141 | 2 | 30114334 | |
| Pubmed | Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. | 1.63e-05 | 2 | 141 | 2 | 14970861 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22406480 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 12021262 | ||
| Pubmed | ZFP281 Recruits MYC to Active Promoters in Regulating Transcriptional Initiation and Elongation. | 1.63e-05 | 2 | 141 | 2 | 31570506 | |
| Pubmed | Phosphorylation of Hrs downstream of the epidermal growth factor receptor. | 1.63e-05 | 2 | 141 | 2 | 12180964 | |
| Pubmed | Serpinb3 is overexpressed in the liver in presence of iron overload. | 1.63e-05 | 2 | 141 | 2 | 28935635 | |
| Pubmed | A complex of BRCA2 and PP2A-B56 is required for DNA repair by homologous recombination. | 1.63e-05 | 2 | 141 | 2 | 34593815 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 37980563 | ||
| Pubmed | c-Myc is required for transformation of FDC-P1 cells by EGFRvIII. | 1.63e-05 | 2 | 141 | 2 | 17499721 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 TPR CCT3 MAP1B ETFA CKAP5 DCTN1 NSUN2 LRRIQ1 P4HB AGL ZRANB2 AGFG1 DDX20 RPL3 ZC3HAV1 | 1.83e-05 | 1149 | 141 | 16 | 35446349 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | TPM4 TPR CCT3 MAP1B RPAP3 CKAP5 NSUN2 PPP2R5A P4HB DDX20 RPL3 | 2.36e-05 | 573 | 141 | 11 | 28330616 |
| Pubmed | 3.02e-05 | 216 | 141 | 7 | 31519766 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRN MIA3 MAP1B FAM53A MYRIP AHCYL2 SMG7 EGFR ZNF532 TECPR2 VPS35L SHPRH MKLN1 FNIP1 RASEF ZFHX3 BOD1L1 ZC3HAV1 | 3.49e-05 | 1489 | 141 | 18 | 28611215 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 3.50e-05 | 221 | 141 | 7 | 29991511 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM4 MIA3 CCT3 RPAP3 ETFA BMS1 ZDBF2 AHCYL2 LMNB2 ZZEF1 TRIP11 AKAP9 PTAR1 DDX20 SMCR8 SUCO RPL3 ZC3HAV1 | 3.71e-05 | 1496 | 141 | 18 | 32877691 |
| Pubmed | 3.81e-05 | 152 | 141 | 6 | 34299191 | ||
| Pubmed | Proteomic analysis of SARS-CoV-2 particles unveils a key role of G3BP proteins in viral assembly. | 3.98e-05 | 93 | 141 | 5 | 38245532 | |
| Pubmed | BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates. | 4.03e-05 | 226 | 141 | 7 | 25900982 | |
| Pubmed | 4.32e-05 | 312 | 141 | 8 | 37120454 | ||
| Pubmed | MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival. | 4.88e-05 | 3 | 141 | 2 | 20587524 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 11971876 | ||
| Pubmed | Up-regulation of miR-1245 by c-myc targets BRCA2 and impairs DNA repair. | 4.88e-05 | 3 | 141 | 2 | 22158906 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 30137358 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 21878643 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 30298963 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 9250878 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 11079161 | ||
| Interaction | NAA40 interactions | TPM4 TPP2 TPR CCT3 MAP1B RPAP3 ECD ETFA RSF1 CKAP5 PDCD2L ARFIP1 DCTN1 NSUN2 TRIP11 R3HCC1L SMG7 AGFG1 BOD1L1 CGNL1 SIPA1L2 SMCR8 ZNF281 RPL3 ZC3HAV1 | 1.28e-08 | 978 | 139 | 25 | int:NAA40 |
| Interaction | AURKB interactions | MYC TPM4 DLG5 MIA3 CCT3 MAP1B RPAP3 ZZEF1 DCTN1 NSUN2 DICER1 EVI5 FRK BRCA2 EGFR P4HB AGL DDX20 RPL3 ZC3HAV1 | 2.80e-07 | 761 | 139 | 20 | int:AURKB |
| Interaction | NUP43 interactions | CASP8AP2 CCT3 ZC3H13 RSF1 BMS1 ZDBF2 TRIP12 FSIP2 PAXBP1 BRCA2 EGFR ZNF532 ZFHX3 BOD1L1 ZNF281 RPL3 ZMYM3 | 1.49e-06 | 625 | 139 | 17 | int:NUP43 |
| Interaction | NDC80 interactions | DLG5 MIA3 CKAP5 DCTN1 NSUN2 CEP63 NHSL1 CCDC66 AKAP9 EGFR HGS PLS1 | 1.77e-06 | 312 | 139 | 12 | int:NDC80 |
| Interaction | STIL interactions | 6.96e-06 | 190 | 139 | 9 | int:STIL | |
| Interaction | GSK3B interactions | MYC DLG5 MIA3 MAP1B ECD GPS1 ZDBF2 DCTN1 NSUN2 TRIP12 DICER1 NHSL1 SMG7 P4HB SERPINB4 FNIP1 DDX20 SIPA1L2 ZNF281 | 8.29e-06 | 868 | 139 | 19 | int:GSK3B |
| Interaction | PHIP interactions | 9.31e-06 | 197 | 139 | 9 | int:PHIP | |
| Interaction | ANAPC13 interactions | 1.04e-05 | 72 | 139 | 6 | int:ANAPC13 | |
| Interaction | PFN1 interactions | MYC TPR DLG5 ARFIP1 TRIP11 NHSL1 R3HCC1L AKAP9 SMG7 BOD1L1 DDX20 SIPA1L2 LRIF1 MTSS2 | 1.18e-05 | 509 | 139 | 14 | int:PFN1 |
| Interaction | PAFAH1B1 interactions | 1.25e-05 | 258 | 139 | 10 | int:PAFAH1B1 | |
| Interaction | KBTBD4 interactions | 1.25e-05 | 316 | 139 | 11 | int:KBTBD4 | |
| Interaction | SIRT7 interactions | TPP2 TPR CCT3 MAP1B ZC3H13 RSF1 BMS1 CKAP5 LMNB2 NSUN2 TRIP12 DICER1 P4HB DDX20 RPL3 ZMYM3 ZC3HAV1 | 1.49e-05 | 744 | 139 | 17 | int:SIRT7 |
| Interaction | ACTB interactions | MYC TPM4 NRAP CCT3 MAP1B AHCYL2 NEB ARFIP1 DCTN1 NEDD8 FSIP2 NHSL1 CCDC66 EGFR P4HB ZRANB2 SIPA1L2 RPL3 PLS1 MEGF10 MTSS2 | 1.68e-05 | 1083 | 139 | 21 | int:ACTB |
| Interaction | CIT interactions | TPM4 TPR CCT3 RPAP3 ZC3H13 ETFA RSF1 BMS1 CKAP5 LMNB2 GRIN2B ZZEF1 DCTN1 NSUN2 TRIP12 PAXBP1 AKAP9 P4HB HGS BOD1L1 DDX20 ZNF281 RPL3 PLS1 ZC3HAV1 | 1.80e-05 | 1450 | 139 | 25 | int:CIT |
| Interaction | CEP135 interactions | DLG5 MIA3 CEP63 CCDC88C CCDC66 AKAP9 SMG7 BRCA2 CGNL1 SIPA1L2 | 1.96e-05 | 272 | 139 | 10 | int:CEP135 |
| Interaction | ERCC2 interactions | 2.05e-05 | 81 | 139 | 6 | int:ERCC2 | |
| Interaction | POLR1A interactions | 2.25e-05 | 220 | 139 | 9 | int:POLR1A | |
| Interaction | FDXR interactions | 2.36e-05 | 83 | 139 | 6 | int:FDXR | |
| Interaction | AKAP4 interactions | 2.62e-05 | 9 | 139 | 3 | int:AKAP4 | |
| Interaction | PHF21A interactions | MYC TPR CASP8AP2 RPAP3 CKAP5 ZDBF2 NEDD8 ZFHX4 BRCA2 ZFHX3 ZMYM3 | 2.66e-05 | 343 | 139 | 11 | int:PHF21A |
| Interaction | KCNA3 interactions | TPR DLG5 CCT3 MAP1B RPAP3 ABCA13 ICE2 CKAP5 ARFIP1 SLC38A1 CCDC88C EGFR HGS BOD1L1 SMCR8 RPL3 PHTF1 ZC3HAV1 | 3.14e-05 | 871 | 139 | 18 | int:KCNA3 |
| Interaction | BAP1 interactions | MYC TPM4 TPR CCT3 MAP1B ZC3H13 ETFA CKAP5 AHCYL2 DCTN1 NSUN2 LRRIQ1 BRCA2 EGFR P4HB AGL DHODH ZRANB2 AGFG1 DDX20 SUCO RPL3 ZC3HAV1 | 3.25e-05 | 1314 | 139 | 23 | int:BAP1 |
| Interaction | SNRNP40 interactions | MYC CASP8AP2 ZC3H13 ECD GPS1 RSF1 BMS1 ZDBF2 PAXBP1 BRCA2 EGFR ZNF532 ZFHX3 ZNF281 RPL3 | 3.48e-05 | 637 | 139 | 15 | int:SNRNP40 |
| Interaction | LAD1 interactions | 3.50e-05 | 54 | 139 | 5 | int:LAD1 | |
| Interaction | NIN interactions | MIA3 ETFA CKAP5 DCTN1 CEP63 CCDC66 SMG7 BRCA2 CGNL1 SIPA1L2 CPLANE1 | 4.03e-05 | 359 | 139 | 11 | int:NIN |
| Interaction | GOLGA1 interactions | 4.06e-05 | 183 | 139 | 8 | int:GOLGA1 | |
| Interaction | YWHAG interactions | MYC DLG5 RPAP3 ZC3H13 CKAP5 DZIP1 TRIP12 TRIP11 CCDC88C NHSL1 AKAP9 P4HB SHPRH AGFG1 FNIP1 BOD1L1 CGNL1 SIPA1L2 SUCO ZMYM3 MTSS2 ZC3HAV1 | 4.43e-05 | 1248 | 139 | 22 | int:YWHAG |
| Interaction | DYNC1LI1 interactions | 5.37e-05 | 246 | 139 | 9 | int:DYNC1LI1 | |
| Interaction | KLHL40 interactions | 5.39e-05 | 59 | 139 | 5 | int:KLHL40 | |
| Interaction | GRK4 interactions | 5.90e-05 | 31 | 139 | 4 | int:GRK4 | |
| Interaction | SUMO2 interactions | MYC TPR CASP8AP2 ERCC6 CCT3 CKAP5 NSUN2 TRIP12 EGFR P4HB BOD1L1 TOPORS RPL3 ZMYM3 | 6.04e-05 | 591 | 139 | 14 | int:SUMO2 |
| Interaction | H2BC9 interactions | CASP8AP2 DNAH10 MAP1B ABCA13 CKAP5 NEB ARFIP1 NEDD8 FSIP2 CCDC88C GTF2H3 ZFHX4 | 6.29e-05 | 446 | 139 | 12 | int:H2BC9 |
| Interaction | GAN interactions | 6.67e-05 | 253 | 139 | 9 | int:GAN | |
| Interaction | YWHAB interactions | MYC DLG5 RPAP3 DZIP1 NEB DCTN1 TRIP12 TRIP11 CCDC88C NHSL1 AKAP9 EGFR P4HB HGS ZRANB2 CGNL1 SIPA1L2 SUCO MTSS2 | 6.99e-05 | 1014 | 139 | 19 | int:YWHAB |
| Interaction | FCRL5 interactions | 8.73e-05 | 13 | 139 | 3 | int:FCRL5 | |
| Interaction | GSK3A interactions | MYC DLG5 MIA3 ECD ZDBF2 DICER1 NHSL1 AKAP9 SMG7 FNIP1 SIPA1L2 TOPORS | 9.15e-05 | 464 | 139 | 12 | int:GSK3A |
| Interaction | ZYX interactions | 9.73e-05 | 329 | 139 | 10 | int:ZYX | |
| Interaction | PHLPP1 interactions | 1.07e-04 | 333 | 139 | 10 | int:PHLPP1 | |
| Interaction | AGBL4 interactions | 1.23e-04 | 70 | 139 | 5 | int:AGBL4 | |
| Interaction | ALOX5 interactions | 1.60e-04 | 74 | 139 | 5 | int:ALOX5 | |
| Interaction | UBE2M interactions | MYC CCT3 MAP1B GPS1 CKAP5 LMNB2 DCTN1 NEDD8 EGFR P4HB AGL UHMK1 ZRANB2 RPL3 | 1.67e-04 | 651 | 139 | 14 | int:UBE2M |
| Interaction | LUC7L2 interactions | 1.73e-04 | 353 | 139 | 10 | int:LUC7L2 | |
| Interaction | RNF123 interactions | VIL1 ATRN CCT3 TOPAZ1 ZC3H13 BMS1 CKAP5 LMNB2 ZZEF1 TRIP12 R3HCC1L EBLN1 AGL BOD1L1 PLS1 MEGF10 | 1.82e-04 | 824 | 139 | 16 | int:RNF123 |
| Interaction | DCTN2 interactions | 1.85e-04 | 356 | 139 | 10 | int:DCTN2 | |
| Interaction | PDGFRB interactions | 1.88e-04 | 228 | 139 | 8 | int:PDGFRB | |
| Interaction | ERCC3 interactions | 2.15e-04 | 175 | 139 | 7 | int:ERCC3 | |
| Interaction | SHLD2 interactions | 2.17e-04 | 43 | 139 | 4 | int:SHLD2 | |
| Interaction | PRMT1 interactions | MYC TPR CCT3 MAP1B ZC3H13 BMS1 CKAP5 NSUN2 CCDC88C PAXBP1 EGFR P4HB DDX20 TOPORS RPL3 LRIF1 ZC3HAV1 | 2.29e-04 | 929 | 139 | 17 | int:PRMT1 |
| Interaction | PRMT3 interactions | 2.42e-04 | 126 | 139 | 6 | int:PRMT3 | |
| Interaction | LATS1 interactions | MYC DLG5 MIA3 MAP1B CKAP5 NEB TRIP11 CCDC88C AKAP9 SMG7 SIPA1L2 | 2.42e-04 | 440 | 139 | 11 | int:LATS1 |
| Interaction | CHD4 interactions | MYC TPR ERCC6 RSF1 BMS1 DCTN1 TRIP12 PAXBP1 ZFHX4 BRCA2 EGFR SHPRH ZFHX3 RPL3 LRIF1 ZMYM3 ZC3HAV1 | 2.56e-04 | 938 | 139 | 17 | int:CHD4 |
| Interaction | SYNE3 interactions | DLG5 MIA3 CEP63 CCDC66 SMG7 BRCA2 P4HB HGS CGNL1 SIPA1L2 ZC3HAV1 | 2.62e-04 | 444 | 139 | 11 | int:SYNE3 |
| Interaction | TOMM20 interactions | 2.66e-04 | 240 | 139 | 8 | int:TOMM20 | |
| Interaction | CUL4A interactions | MYC TPR MIA3 ERCC6 MAP1B ZC3H13 GPS1 RSF1 CKAP5 LMNB2 DCTN1 DICER1 NEDD8 EGFR SYCP1 PLS1 | 2.72e-04 | 854 | 139 | 16 | int:CUL4A |
| Interaction | CDK9 interactions | MYC TPM4 VIL1 TPR CCT3 ZC3H13 BMS1 CKAP5 NSUN2 TRIP12 BRCA2 EGFR P4HB AGL | 2.81e-04 | 685 | 139 | 14 | int:CDK9 |
| Interaction | ZFPL1 interactions | DLG5 ARFIP1 TRIP11 SLC38A1 EGFR SERPINB3 SERPINB4 HGS AGFG1 SMCR8 ZC3HAV1 | 2.82e-04 | 448 | 139 | 11 | int:ZFPL1 |
| Interaction | PLAC8L1 interactions | 2.87e-04 | 19 | 139 | 3 | int:PLAC8L1 | |
| Interaction | CSK interactions | ETFA TRIP11 ADGRL4 CC2D2B SLC38A1 EVI5 FRK MELTF PPP2R5A EGFR PTPRZ1 SERPINB4 SYCP1 SUN3 LRRD1 ZC3HAV1 | 2.98e-04 | 861 | 139 | 16 | int:CSK |
| Interaction | SFN interactions | MYC MAP1B RPAP3 NEB TRIP12 TRIP11 CCDC88C AKAP9 EGFR SERPINB3 ZRANB2 CGNL1 SIPA1L2 MTSS2 | 3.11e-04 | 692 | 139 | 14 | int:SFN |
| Interaction | SERBP1 interactions | MYC TPP2 CCT3 MAP1B ZC3H13 GPS1 ETFA CKAP5 NSUN2 TRIP12 NEDD8 SMG7 EGFR P4HB HGS DHODH ZRANB2 AGFG1 TOPORS RPL3 PLS1 ZC3HAV1 | 3.21e-04 | 1432 | 139 | 22 | int:SERBP1 |
| Interaction | DNAJC17 interactions | 3.37e-04 | 134 | 139 | 6 | int:DNAJC17 | |
| Interaction | NINL interactions | DLG5 CKAP5 DCTN1 CCDC88C CCDC66 SMG7 BRCA2 ZRANB2 ZFHX3 CGNL1 SIPA1L2 | 3.41e-04 | 458 | 139 | 11 | int:NINL |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 3.24e-04 | 29 | 84 | 3 | 396 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 8.47e-07 | 139 | 140 | 8 | M6754 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MYC ATRN MAP1B CKAP5 ZZEF1 TRIP12 ZNF804A DICER1 EVI5 PPP2R5A AKAP9 BRCA2 EGFR MKLN1 AGFG1 ZFHX3 SUCO | 3.40e-06 | 856 | 140 | 17 | M4500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | CASP8AP2 MAP1B RPAP3 HAP1 ICE2 CKAP5 ZDBF2 AHCYL2 NSUN2 DICER1 CEP63 SLC38A1 LHX1 CCDC88C CCDC66 AKAP9 SMG7 BRCA2 PTPRZ1 UHMK1 BOD1L1 LRIF1 PHTF1 | 1.15e-07 | 989 | 139 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPM4 TPP2 TPR CASP8AP2 TTC41P SPP1 ICE2 ZC3H13 RSF1 CKAP5 ZDBF2 DICER1 EVI5 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 ZFHX3 BOD1L1 CPLANE1 TOPORS ZNF281 LRIF1 | 2.05e-06 | 1257 | 139 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPM4 TPP2 TPR CASP8AP2 TTC41P MAP1B SPP1 ICE2 ZC3H13 RSF1 CKAP5 ZDBF2 DICER1 EVI5 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 ZFHX3 BOD1L1 CPLANE1 TOPORS ZNF281 LRIF1 | 8.25e-06 | 1459 | 139 | 25 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPM4 TPP2 CASP8AP2 ERCC6 MAP1B RPAP3 RSF1 CKAP5 ZDBF2 CEP63 SMG7 BRCA2 ZRANB2 TOPORS | 1.08e-05 | 532 | 139 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR CASP8AP2 TTC41P MAP1B ICE2 ZC3H13 SKIDA1 CKAP5 MYRIP ZDBF2 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 BBS7 BOD1L1 ZNF281 LRIF1 PHTF1 | 1.92e-05 | 1060 | 139 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | TPP2 TPR COL17A1 MAP1B DZIP1 TRIP12 AKAP9 ZFHX4 EGFR ABCA5 PTPRZ1 UHMK1 SHPRH MKLN1 CPLANE1 SUCO MEGF10 | 2.14e-05 | 806 | 139 | 17 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | TPR ERCC6 COL17A1 DNAH10 HAP1 ICE2 CKAP5 LHX1 CCDC66 PAXBP1 AKAP9 ZFHX4 BRCA2 RASEF ZFHX3 BOD1L1 PLS1 LRIF1 MTSS2 | 2.48e-05 | 989 | 139 | 19 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 3.16e-05 | 186 | 139 | 8 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR CASP8AP2 TTC41P MAP1B ICE2 ZC3H13 SKIDA1 CKAP5 MYRIP ZDBF2 ZNF804A ADGRL4 LHX1 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 BBS7 BOD1L1 ZNF281 LRIF1 PHTF1 | 4.52e-05 | 1414 | 139 | 23 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.87e-05 | 203 | 139 | 8 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | COL17A1 DNAH10 HAP1 CKAP5 LHX1 CCDC66 AKAP9 ZFHX4 BRCA2 RASEF PLS1 LRIF1 | 9.75e-05 | 492 | 139 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | CASP8AP2 MAP1B RPAP3 HAP1 CKAP5 ZDBF2 CEP63 LHX1 CCDC88C AKAP9 BRCA2 PTPRZ1 | 1.09e-04 | 498 | 139 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#3_top-relative-expression-ranked_500 | 1.22e-04 | 117 | 139 | 6 | gudmap_developingKidney_e15.5_Medullary collecting duct_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 1.48e-04 | 232 | 139 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.63e-04 | 369 | 139 | 10 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPM4 TPP2 TPR CASP8AP2 TTC41P CCT3 ICE2 RSF1 CKAP5 ZDBF2 DZIP1 EVI5 CCDC66 AKAP9 BRCA2 ZFHX3 BOD1L1 TOPORS ZNF281 LRIF1 | 1.70e-04 | 1241 | 139 | 20 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.14e-04 | 311 | 139 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | TTC39B CASP8AP2 DNAH10 MAP1B HAP1 CKAP5 ZDBF2 AHCYL2 S1PR1 LHX1 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 UHMK1 SIPA1L2 | 2.41e-04 | 983 | 139 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | ERCC6 MAP1B HAP1 ZDBF2 CEP63 CCDC88C SMG7 PTPRZ1 ZRANB2 SHPRH | 2.81e-04 | 395 | 139 | 10 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.13e-04 | 259 | 139 | 8 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 3.85e-04 | 94 | 139 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | CASP8AP2 DNAH10 MAP1B HAP1 CKAP5 ZDBF2 CCDC88C CCDC66 AKAP9 BRCA2 PTPRZ1 | 4.09e-04 | 493 | 139 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATRN RSF1 CKAP5 TRIP11 FRK AKAP9 PTAR1 UHMK1 CPLANE1 SMCR8 ZNF281 | 3.08e-11 | 193 | 141 | 11 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.46e-08 | 198 | 141 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 184 | 141 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 184 | 141 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-07 | 184 | 141 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.44e-07 | 199 | 141 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.44e-07 | 199 | 141 | 8 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.44e-07 | 199 | 141 | 8 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.94e-07 | 138 | 141 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-07 | 160 | 141 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-07 | 160 | 141 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 178 | 141 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-06 | 185 | 141 | 7 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 2.51e-06 | 190 | 141 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-06 | 193 | 141 | 7 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.79e-06 | 193 | 141 | 7 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 195 | 141 | 7 | 8d286622f86c844d1b06a106ee4a3f813eba05bb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 195 | 141 | 7 | 4193e58788e90c3d1049ef5cf9800a8c4d8ac354 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 195 | 141 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.99e-06 | 195 | 141 | 7 | 359b9d791e26844675c3c60cf69d8ab69c2cf400 | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 196 | 141 | 7 | a90c76d9c57a4491b94a321ba541b792ec5d8e83 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-06 | 196 | 141 | 7 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.09e-06 | 196 | 141 | 7 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | Bronchial-NucSeq-Stromal-Schwann-Schwann_nonmyelinating|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-06 | 197 | 141 | 7 | 4a7ff67bb0754e034e6f2a1bd34cde86ee3ef899 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | de5987588b9fa9ee8c595ba06d7d844ead0e3c74 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-06 | 198 | 141 | 7 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 3.41e-06 | 199 | 141 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-06 | 199 | 141 | 7 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.53e-06 | 200 | 141 | 7 | 1fa29a9f42987549a75dffeb177099458f7cca88 | |
| ToppCell | Bronchial_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.53e-06 | 200 | 141 | 7 | 7595eb2a8af3de879ecaa71f3d96f890e13b59ce | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.30e-05 | 162 | 141 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.60e-05 | 168 | 141 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 172 | 141 | 6 | f2c17c49b375b28ad47dc6cabda62f1c238023dd | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 172 | 141 | 6 | 6ab4f01098dddb789df298ddf97b3c384405ee6c | |
| ToppCell | droplet-Fat-Scat-21m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 173 | 141 | 6 | f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 173 | 141 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | COPD-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 2.22e-05 | 178 | 141 | 6 | 441d1dba720141891b11f404744c59834d80e6c5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_pre_proliferating_SCP_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.52e-05 | 182 | 141 | 6 | bfb725fff3d20066d8ac0a6ba2f88498fcbd876e | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 2.67e-05 | 184 | 141 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 186 | 141 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-myofibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.02e-05 | 188 | 141 | 6 | 116ca07ee4413dcc0e9e5ac99bfee6ed7b7847c6 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 191 | 141 | 6 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.30e-05 | 191 | 141 | 6 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 192 | 141 | 6 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 192 | 141 | 6 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 192 | 141 | 6 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 3.39e-05 | 192 | 141 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.39e-05 | 192 | 141 | 6 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | 7c34abdcb8839b9fb25457a79af6c5e7b9714b21 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-05 | 193 | 141 | 6 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.60e-05 | 194 | 141 | 6 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 195 | 141 | 6 | fc75f04eb475c8139cc5c35e6be22e73fb2be9e6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.70e-05 | 195 | 141 | 6 | 83d45ff5e5bc704448431149fffb2e4c1278f279 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.81e-05 | 196 | 141 | 6 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | ILEUM-non-inflamed-(9)_Enteric_neurons|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.81e-05 | 196 | 141 | 6 | 998aa523555ed6bc9c1b5cacbf7ba77c7b218e6b | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.81e-05 | 196 | 141 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | ILEUM-non-inflamed-(9)_Neuro_cell|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.81e-05 | 196 | 141 | 6 | 2b08cd6730119d5dea0152709ab8de580b66cd3c | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-05 | 197 | 141 | 6 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | 3'-Broncho-tracheal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.92e-05 | 197 | 141 | 6 | 5d33f8a6940431093e927b186fb9b630a89d8ec1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-05 | 197 | 141 | 6 | de772bd2b4cda843777ac879b1087e6444199dfb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.92e-05 | 197 | 141 | 6 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | 3'-Broncho-tracheal-Epithelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-05 | 198 | 141 | 6 | aa6e7218ee6230902854e66c444b544218b30c0e | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 2488ea95003f218afb25ecc873805b825e6cc409 | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal-Glial_mature-Adult_Glia|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 991db02a76f7506848827601e927cf997cb520d3 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 3'-Adult-LargeIntestine-Neuronal-Glial_mature|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-05 | 198 | 141 | 6 | 98ab27335d126fa7817a46953948e524d91248f8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.14e-05 | 199 | 141 | 6 | 974f71b56f66243c78f2f297a1540e0e186df530 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.14e-05 | 199 | 141 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.14e-05 | 199 | 141 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-05 | 199 | 141 | 6 | 4099df3c052a9536d72ba01492317be7d83a79ad | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.14e-05 | 199 | 141 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.14e-05 | 199 | 141 | 6 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 4.14e-05 | 199 | 141 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.26e-05 | 200 | 141 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Tracheal-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | efd461c687155c84ef590352207e6fe4ba392a90 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.26e-05 | 200 | 141 | 6 | 99997c447f2b59324fe69c17593db72d972c0cc4 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.26e-05 | 200 | 141 | 6 | 5ed450e65edff713ad5feba4f6c46209bf471f6e | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 4.26e-05 | 200 | 141 | 6 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Intermediate|1m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 805f50236113713b02f77aa5e208efb3b3b959d5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-05 | 200 | 141 | 6 | 2a9d715aba8bdef2341b0d44ff60825c074a4b03 | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.26e-05 | 200 | 141 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.26e-05 | 200 | 141 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.04e-05 | 135 | 141 | 5 | b128596653a5e3b64ed7f657bbfeda35438e2e48 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.55e-05 | 144 | 141 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.86e-05 | 145 | 141 | 5 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 146 | 141 | 5 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 150 | 141 | 5 | ecc4fc94958cf2378dd003966dccba81b3c00f8e | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.27e-04 | 153 | 141 | 5 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| Drug | geldanamycin | TPM4 TPP2 TPR MAP1B ICE2 ARFIP1 SLC38A1 EVI5 ZFHX4 EGFR PTAR1 UHMK1 AGFG1 BOD1L1 | 6.78e-08 | 371 | 139 | 14 | ctd:C001277 |
| Drug | terbufos | MYC NRAP DNAH10 MYRIP GRIK3 DZIP1 S1PR1 LHX1 ABCA5 TMEM132D BARHL1 SYCP1 CD48 RASEF ZFHX3 MEGF10 ZMYM3 | 2.12e-06 | 724 | 139 | 17 | ctd:C012568 |
| Drug | Fonofos | NRAP DNAH10 MYRIP GRIK3 DZIP1 S1PR1 LHX1 ABCA5 TMEM132D BARHL1 SYCP1 CD48 RASEF ZFHX3 MEGF10 ZMYM3 | 7.78e-06 | 714 | 139 | 16 | ctd:D004397 |
| Drug | Parathion | NRAP DNAH10 MYRIP GRIK3 DZIP1 S1PR1 LHX1 EGFR ABCA5 TMEM132D BARHL1 SYCP1 CD48 RASEF ZFHX3 MEGF10 ZMYM3 | 1.13e-05 | 822 | 139 | 17 | ctd:D010278 |
| Disease | Odontochondrodysplasia | 2.17e-05 | 2 | 138 | 2 | cv:C2745953 | |
| Disease | information processing speed | 5.05e-05 | 85 | 138 | 5 | EFO_0004363 | |
| Disease | Adenocarcinoma of prostate | 1.08e-04 | 20 | 138 | 3 | C0007112 | |
| Disease | Small cell carcinoma of lung | 1.21e-04 | 54 | 138 | 4 | C0149925 | |
| Disease | anxiety measurement | 1.58e-04 | 108 | 138 | 5 | EFO_0009863 | |
| Disease | Carcinoma of lung | 1.66e-04 | 23 | 138 | 3 | C0684249 | |
| Disease | cortical surface area measurement | DCHS2 FSIP1 ZC3H13 ETFA SKIDA1 S1PR1 SLC38A1 EVI5 CCDC88C NHSL1 LRRIQ1 EGFR VPS35L AGFG1 ZFHX3 AGBL1 PLS1 | 1.88e-04 | 1345 | 138 | 17 | EFO_0010736 |
| Disease | visuospatial function measurement | 2.41e-04 | 26 | 138 | 3 | EFO_0803533 | |
| Disease | Alzheimer disease | 4.80e-04 | 485 | 138 | 9 | MONDO_0004975 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 5.56e-04 | 301 | 138 | 7 | DOID:684 (is_marker_for) | |
| Disease | Nephroblastoma | 6.38e-04 | 36 | 138 | 3 | C0027708 | |
| Disease | Autism Spectrum Disorders | 6.92e-04 | 85 | 138 | 4 | C1510586 | |
| Disease | Glioma | 7.55e-04 | 87 | 138 | 4 | C0017638 | |
| Disease | Malignant tumor of prostate | 7.65e-04 | 9 | 138 | 2 | cv:C0376358 | |
| Disease | colorectal cancer (is_marker_for) | 8.78e-04 | 157 | 138 | 5 | DOID:9256 (is_marker_for) | |
| Disease | glucagon-like peptide-1 measurement | 9.53e-04 | 10 | 138 | 2 | EFO_0008465 | |
| Disease | Pancreatic Neoplasm | 1.27e-03 | 100 | 138 | 4 | C0030297 | |
| Disease | Malignant neoplasm of pancreas | 1.37e-03 | 102 | 138 | 4 | C0346647 | |
| Disease | Osteosarcoma | 1.40e-03 | 47 | 138 | 3 | C0029463 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.58e-03 | 49 | 138 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | facial morphology measurement | 1.62e-03 | 466 | 138 | 8 | EFO_0007841 | |
| Disease | Erythrocyte Mean Corpuscular Hemoglobin Test | 1.64e-03 | 13 | 138 | 2 | C0369183 | |
| Disease | Finding of Mean Corpuscular Hemoglobin | 1.64e-03 | 13 | 138 | 2 | C1261502 | |
| Disease | Colorectal Carcinoma | 1.76e-03 | 702 | 138 | 10 | C0009402 | |
| Disease | nephroblastoma (is_implicated_in) | 1.90e-03 | 14 | 138 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | Neoplasm of lung | 1.90e-03 | 14 | 138 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 1.90e-03 | 14 | 138 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.90e-03 | 14 | 138 | 2 | 211980 | |
| Disease | Asbestosis | 1.90e-03 | 14 | 138 | 2 | C0003949 | |
| Disease | Pulmonary Fibrosis - from Asbestos Exposure | 1.90e-03 | 14 | 138 | 2 | C2930617 | |
| Disease | vital capacity | DIS3L2 FSIP1 ZZEF1 TRIP12 TRIP11 ADGRL4 MEOX2 MELTF PRDM11 R3HCC1L LRRIQ1 HGS SYCP1 ZFHX3 | 2.00e-03 | 1236 | 138 | 14 | EFO_0004312 |
| Disease | Carcinoma, Granular Cell | 2.19e-03 | 116 | 138 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 2.19e-03 | 116 | 138 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 2.19e-03 | 116 | 138 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 2.19e-03 | 116 | 138 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 2.19e-03 | 116 | 138 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 2.19e-03 | 116 | 138 | 4 | C0001418 | |
| Disease | MMR-related febrile seizures | 2.19e-03 | 15 | 138 | 2 | EFO_0006519 | |
| Disease | prostate cancer (is_implicated_in) | 2.26e-03 | 117 | 138 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | nervousness | 2.50e-03 | 16 | 138 | 2 | NCIT_C74532 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.82e-03 | 17 | 138 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | calcium measurement | 2.86e-03 | 628 | 138 | 9 | EFO_0004838 | |
| Disease | Schizophrenia | ABCA13 GPS1 GRIK3 GRIN2B ZNF804A DICER1 PTPRZ1 TMEM245 UHMK1 CGNL1 MEGF10 | 2.98e-03 | 883 | 138 | 11 | C0036341 |
| Disease | APOE carrier status, dementia | 3.09e-03 | 62 | 138 | 3 | EFO_0007659, MONDO_0001627 | |
| Disease | bipolar disorder, sex interaction measurement | 3.16e-03 | 18 | 138 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | serum IgG glycosylation measurement | 3.29e-03 | 523 | 138 | 8 | EFO_0005193 | |
| Disease | ovarian neoplasm | 3.68e-03 | 134 | 138 | 4 | C0919267 | |
| Disease | reaction time measurement | 3.88e-03 | 658 | 138 | 9 | EFO_0008393 | |
| Disease | ethylmalonate measurement | 3.90e-03 | 20 | 138 | 2 | EFO_0020009 | |
| Disease | Malignant neoplasm of ovary | 3.98e-03 | 137 | 138 | 4 | C1140680 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.19e-03 | 139 | 138 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | haptoglobin measurement | 4.30e-03 | 21 | 138 | 2 | EFO_0004640 | |
| Disease | Malignant Glioma | 4.36e-03 | 70 | 138 | 3 | C0555198 | |
| Disease | mixed gliomas | 4.36e-03 | 70 | 138 | 3 | C0259783 | |
| Disease | brain measurement, neuroimaging measurement | 4.45e-03 | 550 | 138 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Malignant neoplasm of liver | 4.52e-03 | 142 | 138 | 4 | C0345904 | |
| Disease | Liver neoplasms | 4.52e-03 | 142 | 138 | 4 | C0023903 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKSKRNYEELSEGNV | 441 | Q8WWZ7 | |
| SLLGYKNNTISAKDT | 171 | Q9HBW9 | |
| DTLKKEKQAAYNADS | 386 | Q9UMD9 | |
| EKQAAYNADSGLKAE | 391 | Q9UMD9 | |
| INDKFTLNKDDASYS | 381 | Q8IWZ6 | |
| EDALKSLENQTYFKS | 2471 | Q99996 | |
| SDGAASSYQLKQLEE | 351 | Q14203 | |
| NVEDKDYKDAASSSS | 51 | Q5JQC9 | |
| LDKSGSNASSDSEYK | 141 | Q9BZE3 | |
| YNADTQKLLAKNGET | 216 | P53367 | |
| ASSGIKSDYEGDLNK | 2781 | Q86UQ4 | |
| KSYLEGSSDNQLKDS | 671 | Q9UHI6 | |
| TLLSNKYLDGNANKS | 1236 | Q9UPY3 | |
| NKSLTQTFGDDKYSL | 641 | Q8IYB7 | |
| YKEENNDSKETSGAL | 651 | Q14692 | |
| KSNSDSDYKGERINS | 306 | Q9UKL3 | |
| NGKKLESLSYLASDE | 446 | Q6DHV5 | |
| TLSKSNQLSKESYDE | 1431 | Q9Y485 | |
| EEASLKGTLDNLKSY | 531 | O95905 | |
| NEASGFEKYLADQAK | 266 | Q03468 | |
| SKLGDDLNSEKTQYA | 366 | Q96MI9 | |
| KKYNLLQDSSTSDSD | 196 | Q96B23 | |
| KKIAGSNYNTFLDSE | 476 | Q7Z5L2 | |
| QADSGSSEEKQLYNK | 21 | P10451 | |
| QSELDALKSDYADQS | 301 | Q8IZ41 | |
| LSSETYSQAKDLAKG | 641 | Q08J23 | |
| NEASGFEKYLADQAK | 266 | P0DP91 | |
| SLKDLGKNSEYNSSN | 1006 | Q96KG7 | |
| NEASDYLEGKSSNQI | 41 | A4D1F6 | |
| KTDATDGKDYNASAS | 1191 | P46821 | |
| TSLYQDKQEGKSTDF | 1451 | P46821 | |
| EKQEKGTLNSNAAYE | 701 | Q5T3J3 | |
| NDEKTAADYKILGGS | 51 | Q15843 | |
| KTNAANLSDARYKES | 1261 | Q86VF7 | |
| TYQAKLDSAKLSSDQ | 281 | Q03252 | |
| GLPSTYNKDLQEDKE | 316 | P04424 | |
| GNSCLKITTAKENYD | 796 | O75882 | |
| LQEDDSGSDTKYKIL | 946 | Q9P219 | |
| LSKALSAKDSYSDEQ | 1961 | Q5CZC0 | |
| LDQTSNKEDAGSLYS | 591 | Q5SYE7 | |
| SDEDKLNNAKYAISV | 576 | Q14651 | |
| ASEQVIKDLKGSDYS | 241 | Q765P7 | |
| LSQSLPNDGDEKYEK | 226 | Q9BRP1 | |
| KSDSNQYIGELKDQI | 686 | O60447 | |
| DTDLKNYKGNSIKES | 146 | Q13098 | |
| KTDKELYENTGQSNF | 106 | Q8N292 | |
| KHNGSSEILNKLYDT | 291 | Q8TDM6 | |
| EDYLSNSSVAKENSL | 116 | P48742 | |
| KRKSDSSDSQEGNYK | 166 | P50222 | |
| SDYDGKLSNFKTAAE | 266 | P07237 | |
| DDNKALSKSEIIYGN | 1036 | P23471 | |
| AFQNSEYGDDSIKKA | 811 | Q9Y5B6 | |
| RKYENTDNKTELGNS | 501 | Q96JM4 | |
| NNYEEKKTSSLDADL | 3026 | Q6V1P9 | |
| ESYNKGEISSGRKDN | 2731 | Q8NFC6 | |
| AEKQLLYSENKTGSF | 126 | P42685 | |
| IGNENKETGTLYASK | 106 | P0CF75 | |
| VLSNYDANKTGLKEL | 121 | P00533 | |
| GSKENTKEGLAELYE | 1841 | Q14008 | |
| AEDSSLLIYKASDGK | 866 | Q659A1 | |
| DKLKGNNYESDVELT | 796 | P51587 | |
| LKNDCNKSASGYLTD | 1196 | P51587 | |
| FKGQSTKSDSAEDYL | 2661 | Q9H799 | |
| NYLKEGSTDNDDATK | 561 | Q0VF96 | |
| LAEKKYTSQGQGDLD | 316 | Q96MT8 | |
| SSSDIKDQCLKYQGS | 106 | Q8TF40 | |
| YGAETEKLQKQLASE | 401 | P54257 | |
| LSLTENGKEAKSQYS | 171 | A2RUB6 | |
| KGTYLTNEAKGAEDA | 396 | Q8N3J6 | |
| NLKKGLSTEDATSAY | 61 | Q8N6N7 | |
| SGKQNKDLYELAFSI | 616 | Q96BJ8 | |
| FKVDTASNLNSGKED | 41 | Q8NA03 | |
| IYSKKEDLESGDGNN | 1446 | Q9ULL0 | |
| SENEKTNDTLLSYFK | 206 | Q8IXS0 | |
| DSADDLAKQTKIEYG | 671 | Q13003 | |
| SGALYISKVQKEDNS | 91 | P09326 | |
| GLEKCQKSLNDYLDS | 1546 | Q8IVF4 | |
| NYKEDSESDGSQKSL | 1216 | Q96T23 | |
| YTGKLNISADKENSI | 31 | P21453 | |
| GTLLSYATEDNDNKL | 311 | Q96A99 | |
| LNKNLISYKHDGSET | 1601 | P0C091 | |
| TELTDEQAKYLGLNK | 586 | Q96HN2 | |
| LNDSSKQGYSQETKR | 341 | Q7Z6K3 | |
| EAYGQKDLLFKDSTS | 316 | P08582 | |
| DFEESKYLLSTNSQK | 996 | Q14C87 | |
| TLKSAYDDTENDLKG | 516 | Q5JRA6 | |
| LLSSGLKNDYNKETF | 101 | Q9UL63 | |
| GKLIKNNASTDYDLS | 296 | P39023 | |
| SEKLASYQAARKDSG | 146 | P01106 | |
| KSGENFKLLYDLADQ | 226 | P13804 | |
| NNRYKSIDGSDETKA | 201 | Q9NQV5 | |
| NEVYGKNLTSSSKAE | 951 | Q92540 | |
| LGKNKTSVDAAEDYA | 181 | Q02127 | |
| SGAEANSEKYSKILH | 626 | Q1XH10 | |
| SKYRAQLDNKTDSTG | 651 | Q9P2F8 | |
| LYLTNLEKSQDKTSG | 1411 | Q149N8 | |
| LDSSLEYKKGESQTD | 241 | P49368 | |
| QKLLTEFNKSTDAYE | 86 | P29508 | |
| EFKELTSKNSALEYQ | 311 | Q86YF9 | |
| KDLDYLKDVNGTTSG | 1071 | P35498 | |
| DKGFYSSQAIEKANE | 221 | Q8TEV9 | |
| NGKLFDDLTSSYKAE | 426 | Q15172 | |
| TNKAGLQTADKYAAL | 316 | P52594 | |
| QEKGYLTQTAAALDK | 6 | Q8NEY3 | |
| NTKSYEDLKAELGNS | 721 | P09327 | |
| QDYDKLKALGGENSS | 171 | Q9HCE3 | |
| REKDYLTSDGSAKNS | 236 | Q86UP3 | |
| ELASLYKSQGEIDKA | 631 | Q5VTQ0 | |
| DKVDSNDSLYGGDSK | 841 | Q7Z3J2 | |
| NSGKRSTADYSLDNE | 281 | P17040 | |
| NNLKSLEAASEKYSE | 166 | P67936 | |
| LASLGSETNKKYSNV | 661 | Q9UMS5 | |
| QALASKENSYPKEAD | 246 | Q9H6T3 | |
| SNLYKSAADDSEAKS | 286 | P12270 | |
| ELGLYKSKEQEQSSL | 731 | Q15431 | |
| IIEAGTSESYKNNKA | 196 | Q8TAQ9 | |
| YEQLNRKAEGKATST | 216 | O14964 | |
| SQVELLNSFEKKYSD | 176 | P29144 | |
| QYVLENKNDKCSGSE | 1026 | Q9HCK1 | |
| DNLAKSASEEYLKEN | 911 | Q6P2S7 | |
| LDQYSNKSESQKEDP | 611 | Q9Y2X9 | |
| QKLLTEFNKSTDAYE | 86 | P48594 | |
| DDKGKIVYSSLDLDQ | 146 | O15040 | |
| NASDNLKNESSDYTK | 236 | Q9UBS9 | |
| LDYNTGEDKSSKNLL | 481 | Q9UBS9 | |
| SKYNLDASEEEDSNK | 181 | O95218 | |
| EESDLYQSKTNGLLS | 296 | Q8N9V7 | |
| LYEKQNGKESSGAEL | 256 | Q9H330 | |
| KLDGNYKNESDTFSD | 831 | Q9NS56 | |
| DSDNNSKLQVDYTGL | 1256 | Q15643 | |
| YLQLKSTDSGAKDLA | 976 | O43149 | |
| NAVKLGKYEDSNSVT | 56 | B7Z8K6 | |
| DKRKNSNVDSSYLES | 626 | Q7Z2W4 | |
| ALYKAFSTSEQDKDN | 411 | Q7Z2W7 | |
| SNTSGYSESKKDDAR | 806 | Q14669 | |
| YANAGDSKAAQKLLT | 376 | Q8TAS1 | |
| SLYLKITDQDGDKGT | 436 | Q9H2H9 | |
| SKDGKYELLTSANEV | 96 | Q13889 | |
| QSKYANGETSKGDEL | 1076 | Q14202 | |
| YNSGDDKNEKHRLLS | 851 | Q5T200 | |
| VRHKSNKDYLNSDGS | 236 | Q15911 | |
| KNGNKTLDYAEKENT | 31 | Q7Z570 | |
| LKNSKSLCSLNYEDD | 296 | Q6NSI3 | |
| DSDKYCKLNLQQSGS | 76 | P35573 | |
| ISKAEAYGDSLDKQN | 206 | Q8NFW9 | |
| KKAGNLYDISEDNSL | 1246 | Q13224 | |
| NTKQLSDLNYKVEGE | 1496 | P20929 | |
| AKSSLQQSDFEYKLD | 5571 | P20929 |